Explore
Discover market recaps, educational articles, and trading insights.
FIIs continued their selling streak this week, offloading over ₹13,000 crore in the first three days, primarily targeting the IT and Pharma sectors. However, DIIs acted as strong shock absorbers, driving a late-week recovery in the Nifty 50 by pivoting into Financials and Autos.
The Indian market navigates a complex landscape as DII liquidity cushions massive FII outflows while the Nifty 50 settles at 23,775.10. Key highlights include TCS's robust 12% profit growth, Starlink's looming telecom disruption, and a structural pivot in India's manufacturing CAPEX.
This guide outlines five foundational pillars for the 2026 Indian retail investor, ranging from the nuances of shareholding structures to the mechanics of index rebalancing. It provides actionable insights into regulatory protection via SCORES and explains how RBI monetary policy directly influences portfolio valuations.
As volatility rises, the Indian market is witnessing a structural shift from high-beta cyclicals toward the safety of FMCG and Pharma. While the Nifty 50 holds steady at 23,775.10, the divergence between FII selling and DII support is defining the current institutional tug-of-war.
India enters FY27 with a defensive RBI maintaining repo rates at 5.25% and a landmark overhaul of mutual fund regulations. Despite aggressive FII selling exceeding ₹18,000 crore, resilient domestic inflows and structural tax reforms are anchoring the market's new reality.
This comprehensive 2026 guide outlines critical strategies for Indian investors, focusing on Free Cash Flow as a quality filter and technical confluence for trade precision. It highlights the '100 minus Age' rule for asset allocation and the necessity of an emergency fund during high market volatility.
Indian markets are entering a structural 'Great Reset' as the Nifty 50 approaches 24,000 following a significant crash in crude oil prices. This shift is being driven by the New Income Tax Act, a massive regulatory hike in F&O trading costs, and a resurgent IPO pipeline that is forcing institutional rotation.
Divi’s Laboratories reported a resilient Q3 FY26 with income reaching ₹2,692 crores, driven by its high-margin Custom Synthesis segment. While the stock maintains a premium valuation, its fortress-like balance sheet and strategic 'China+1' positioning remain key catalysts for long-term investors.
Indian markets demonstrated structural resilience on April 7, 2026, as domestic institutional buying neutralized a massive FII exit triggered by Brent crude surging past $111. The session was marked by a significant rebound in the Nifty 50, record defense export data, and anticipation ahead of the RBI monetary policy review.
This guide explores essential investing frameworks for Indian retail investors, from the nuances of value vs. growth strategies to the mechanics of portfolio rebalancing. Learn how to size an emergency fund effectively and use technical indicators like RSI to navigate a market where the GIFT Nifty trades near 22,997.
As FIIs withdraw ₹1.19 lakh crore, domestic institutional investors have anchored the Indian market through a strategic shift into defensive sectors like Pharmaceuticals. This analysis explores how margin resilience and 'higher-for-longer' interest rates are reshaping sector leadership in April 2026.